Awardee OrganizationUNIVERSITY OF MICHIGAN AT ANN ARBOR
Description
Abstract Text
Abnormal lamination of the cerebral cortex is presumed to result from an
interference with neuronal migration during development. Despite recent
gains in our understanding of normal development, analysis of the
pathogenesis of migrational abnormalities has been limited by the
inaccessibility of mammalian embryos and by our inability to directly
visualize the abnormal migratory patterns. Recently, however,
recombinant retroviruses have been developed that allow neural
progenitors to be labeled at any stage of embryogenesis. The progeny of
single infected cells can be visualized by histochemical staining and
their routes of migration discerned from their arrangement as they leave
their birthplace. Retroviral studies of normal migration within the
chick optic tectum have allowed detection of even small numbers of
atypically migrating cells. The tectum is a tissue that shares many
structural, functional, and morphogenetic features with the mammalian
cortex, yet is more accessible to injection of virus and to experimental
manipulation during early development. It therefore has the potential
to serve as an excellent model system in which to study the pathogenesis
of migrational abnormalities.
The immediate goals are to determine whether lamination and migration in
the chick optic tectum are disrupted by hypoxia, radiation, infarction,
toxins, and surgical manipulation, and to determine whether the
migrational changes account for the induced pathology. Migratory
pathways will be assessed with recombinant retroviruses, and routine
histological stains, cell type-specific antibodies, electron microscopy
and axonal tracing methods will be used to detect pathology. A
combination of iodo- and bromodeoxyuridine labeling will be employed to
determine the relationship between a cell's birthdate and position. A
novel retroviral marker and Dil will be used to learn if malpositioned
neurons have abnormal axonal projections. The major question to be
answered is whether discrete types of migrational abnormalities cause
specific classes of lamination defects. The long term goal is to
establish a system not only in which to screen potential teratogens for
their effects on the neuronal migration but also in which the mechanisms
of action of these agents may be determined.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
autoradiographycell migrationchick embryocongenital nervous system disorderelectron microscopyembryogenesisepilepsyethanolhypoxiamental retardationmethylmercuryneuroanatomyneurogenesisradiobiologysuperior colliculusteratogenstransposon /insertion element
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
073133571
UEI
GNJ7BBP73WE9
Project Start Date
01-August-1991
Project End Date
31-July-1996
Budget Start Date
01-August-1994
Budget End Date
31-July-1995
Project Funding Information for 1994
Total Funding
$90,720
Direct Costs
$84,000
Indirect Costs
$6,720
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Neurological Disorders and Stroke
$90,720
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K08NS001524-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K08NS001524-04
Patents
No Patents information available for 5K08NS001524-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K08NS001524-04
Clinical Studies
No Clinical Studies information available for 5K08NS001524-04
News and More
Related News Releases
No news release information available for 5K08NS001524-04
History
No Historical information available for 5K08NS001524-04
Similar Projects
No Similar Projects information available for 5K08NS001524-04